Literature DB >> 33680377

Subgrouping of Iranian children and adolescents based on cardiometabolic risk factors using latent class analysis: The CASPIAN-V study.

Abbas Abbasi-Ghahramanloo1, Ramin Heshmat2, Amir-Masood Rafiemanzelat3, Kimia Ghaderi3, Mohammad Esmaeil Motlagh4, Zeinab Ahadi2, Gita Shafiee2, Armita Mahdavi-Gorabi5, Mostafa Qorbani6,7, Roya Kelishadi8.   

Abstract

BACKGROUND: Cardiometabolic syndrome indicates the clustering of several risk factors. The aims of this study were to identify the subgroups of the Iranian children and adolescents on the basis of the components of the cardio-metabolic syndrome and assess the role of demographic characteristics, socioeconomic status and lifestyle-related behaviors on the membership of participants in each latent class.
METHODS: This cross-sectional study was performed on 3730 Iranian students in 2015 using stratified cluster. All students in each class completed anonymous and structured questionnaires. Abdominal obesity, high triglyceride (TG), low high-density lipoprotein (HDL), high blood pressure (BP), high fasting blood sugar (FBS), high low-density lipoprotein (LDL), high cholesterol and obesity were used for assessing the pattern of cardio metabolic risk as a latent variable. Data analysis was performed using PROC LCA in SAS software.
RESULTS: Four latent classes were identified in this study; namely 1) healthy (59.6%), 2) low risk (20.4%), 3) moderate risk (13.7%) and 4) high risk (6.4%). Being a female (OR=0.59, 95% CI: 0.46-0.74), living in a rural area (OR=0.45, 95% CI;0.33-0.60), high screen time (OR=1.56, 95% CI:1.09-2.24), and parental obesity (OR=1.52, 95% CI: 1.18-1.95) were associated with moderate risk class. Only living in rural areas (OR=0.71, 95% CI; 0.51-0.99) was associated with high risk class.
CONCLUSION: About 20% of the students are in the moderate risk and high risk classes. Design and implement interventions according to risk-based class that seem necessary by considering probably risk and protective factors for the prevention of complications of cardiometabolic syndrome.
Copyright © 2020, Babol University of Medical Sciences.

Entities:  

Keywords:  Cardiometabolic; Children and adolescents; Iran; Latent class analysis; Metabolic syndrome

Year:  2020        PMID: 33680377      PMCID: PMC7911770          DOI: 10.22088/cjim.11.4.370

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  24 in total

Review 1.  Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors.

Authors:  J B Meigs
Journal:  Am J Epidemiol       Date:  2000-11-15       Impact factor: 4.897

Review 2.  Menopausal obesity--myth or fact?

Authors:  A Milewicz; U Tworowska; M Demissie
Journal:  Climacteric       Date:  2001-12       Impact factor: 3.005

Review 3.  Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones.

Authors:  Xuewen Wang; Faidon Magkos; Bettina Mittendorfer
Journal:  J Clin Endocrinol Metab       Date:  2011-04       Impact factor: 5.958

Review 4.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

Review 5.  Cardiometabolic syndrome: pathophysiology and treatment.

Authors:  Jonathan P Castro; Fadi A El-Atat; Samy I McFarlane; Ashish Aneja; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

6.  Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X.

Authors:  Biing-Jiun Shen; John F Todaro; Raymond Niaura; Jeanne M McCaffery; Jianping Zhang; Avron Spiro; Kenneth D Ward
Journal:  Am J Epidemiol       Date:  2003-04-15       Impact factor: 4.897

7.  The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome--an analysis by structural equation modelling.

Authors:  J C N Chan; J C K Cheung; C D A Stehouwer; J J Emeis; P C Y Tong; G T C Ko; J S Yudkin
Journal:  Int J Obes Relat Metab Disord       Date:  2002-07

8.  Insulin resistance, insulin response, and obesity as indicators of metabolic risk.

Authors:  Ele Ferrannini; Beverley Balkau; Simon W Coppack; Jacqueline M Dekker; Andrea Mari; John Nolan; Mark Walker; Andrea Natali; Henning Beck-Nielsen
Journal:  J Clin Endocrinol Metab       Date:  2007-05-15       Impact factor: 5.958

9.  Challenges in the treatment of cardiometabolic syndrome.

Authors:  Ambrish K Srivastava
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

10.  Methodology and Early Findings of the Fifth Survey of Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable Disease: The CASPIAN-V Study.

Authors:  Mohammad Esmaeil Motlagh; Hasan Ziaodini; Mostafa Qorbani; Majzoubeh Taheri; Tahereh Aminaei; Azam Goodarzi; Asal Ataie-Jafari; Fatemeh Rezaei; Zeinab Ahadi; Gita Shafiee; Ali Shahsavari; Ramin Heshmat; Roya Kelishadi
Journal:  Int J Prev Med       Date:  2017-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.